Tag Archives: patents

Why Did the Chicken Cross the Road? To Get New Genes!

Posted on December 10, 2015 by Warren Woessner

Jay Cormier has a new post on the FDA Law Blog called “Tastes Like Chicken: Second ‘BioPharm’ Animal Approved to Produce Biological to Treat Orphan Disease Includes 6th Rare Pediatric Disease Priority Review Voucher.” He writes: On December 8, 2015, … Continue reading →

Posted in Supreme Court News | Tagged , , , , , , , | Leave a comment

Ariosa v. Sequenom – Rehearing En Banc Denied

Posted on December 3, 2015 by Warren Woessner

Not surprisingly, the Fed. Cir., on December 2nd, denied Sequenom’s petition for rehearing en banc of the invalidation of certain of the claims of U.S. Pat. No. 6,258,540 which were directed to methods of detecting and using cffDNA. (Appeal no. … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | 1 Comment

Prometheus v. Roxane – A Glimpse of Christmas Future?

Posted on November 16, 2015 by Warren Woessner

A Fed. Cir. panel of Judges Dyk, Taranto and Hughes affirmed the district court’s invalidation of a Prometheus “add-on” patent (U.S. Pat. No. 6,284,770) to a method to treat a form of irritable bowel syndrome, IBS-D, with alosetron, as obvious … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Australian Patent Office Proposes “Coding Only” Sequence Ban

Posted on October 22, 2015 by Warren Woessner

Coming soon after the High Court’s “Myriad decision” in Australia, the Australian Patent Office has proposed guidelines that would effectively limit the ban on patent-eligibility of DNA sequences to nucleic acids that code for polypeptides. While cDNA is still considered … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , | Leave a comment